Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Quick Stats
Jan 30, 202650.4
AI Score
HOLD0.9
Volume Ratio
Mar 17, 2026
Next Earnings
13
+ve Days (30d)
17
-ve Days (30d)
STOK Stock Summary
Last updated Jan 30, 2026
STOK is currently trading at $30.34, positioned above its 200-day moving average of $20.82, indicating a long-term uptrend. The stock has a 52-week range of $5.35 to $38.693.
Technical Analysis: The 50-day moving average stands at $31.23, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 48.3, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.086, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates STOK at 50.4/100 with a HOLD recommendation.
STOK (Stoke Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 48.3 |
| CMF (20) | 0.086 |
| ROC (10) | 3.62 |
| ADX (14) | 18.81 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.444 |
| AROONOSC (14) | -7.143 |
| WILLAMS %R (14) | -21.62 |
| MFI (14) | 33.294 |
STOK Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
STOK Price vs Max Options Open Interest
STOK Max Change In Options Open Interest
STOK Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
STOK Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
STOK Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
STOK Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Stoke Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
STOK Moving Averages Analysis
Stoke Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
STOK (Stoke Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 29.62 |
| 20 | 30.84 |
| 30 | 31.28 |
| 50 | 31.23 |
| 100 | 29.15 |
| 200 | 20.82 |
STOK Fundamental Analysis
| P/E (Forward) | 204.0816 |
| P/E (Trailing) | 44.6176 |
| Market Cap ($) | 1.7 billion |
| Earnings/Share ($) | 0.68 |
| Net Proft Margin (%) | 0.1973 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.0575 |
| EPS Estimate Next Year ($) | -3.1363 |
| WallStreet Target Price ($) | 39.625 |
| Most Recent Quarter |